Clinics & prescribers
For clinics
Patients are asking about peptides. Here's how to meet them with evidence instead of hype.
What patients are asking about
Most questions fall into two groups: FDA-approved peptide medicines (such as GLP-1 receptor agonists) and unapproved compounds patients have read about online (such as BPC-157). These deserve very different conversations.
Key areas for your practice
- Evidence grading: separating approved medicines, human-trial data, and animal-only research.
- Compounding rules: understanding 503A pharmacies, 503B outsourcing facilities, and FDA's bulk drug substance policies.
- Patient education: setting expectations and explaining risks in plain language.
- Monitoring: deciding what follow-up and lab work make sense for each patient.
For a plain-language, patient-friendly reference with evidence grades, see theVictory Peptides library.